- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 06, 2024, 06:44:35 PM
- Local Time:
- May 28, 2024, 09:44:49 AM
- Last Active:
- May 06, 2024, 09:07:39 PM
Signature:
For a lot of endpoints treatments impact is modest from Twenty-four days in all of the topics. This subgroup investigation demonstrates burosumab has